Femasys (FEMY) P/E (2021 - 2026)
Femasys (FEMY) P/E from Jun 30, 2021 to Jun 2, 2026. The TTM Femasys (FEMY) P/E is -1.32. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Femasys (FEMY)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.32 | +17.49% |
| 2025 | -1.12 | -14.74% |
| 2024 | -1.32 | +26.03% |
| 2023 | -1.04 | +6.59% |
| 2022 | -0.98 | -87.87% |
| 2021 | -8.07 | N/A |
Comparison Femasys (FEMY) P/E with competitors
Femasys (FEMY) P/E is -1.32.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -116.99% |
| EMBC | Embecta Corp | 1.73 | -231.01% |
| SOLV | Solventum Corp | 9.19 | -797.30% |
| ZJYL | Jin Medical International Ltd | 14.31 | -1185.44% |
| PDEX | Pro-Dex Inc (co) | 17.38 | -1418.75% |
| UTMD | Utah Medical Products Inc | 19.32 | -1565.75% |
| ATR | Aptargroup Inc | 19.33 | -1566.53% |
| RMD | Resmed Inc | 19.77 | -1599.59% |
| MMSI | Merit Medical Systems Inc | 26.66 | -2122.51% |
| ALGN | Align Technology Inc | 27.22 | -2164.99% |
| COO | Cooper Companies Inc | 29.86 | -2365.08% |
| STVN | Stevanato Group Spa | 29.88 | -2366.91% |
| HOLX | Hologic Inc | 30.86 | -2441.43% |
| LMAT | Lemaitre Vascular Inc | 34.86 | -2744.45% |
| ALC | Alcon Inc | 40.20 | -3149.68% |
| WST | West Pharmaceutical Services Inc | 41.29 | -3232.74% |
| BDX | Becton Dickinson & Company | 44.61 | -3484.08% |
| NEPH | Nephros Inc | 49.38 | -3845.98% |
| ISRG | Intuitive Surgical Inc | 49.96 | -3889.95% |
| NVST | Envista Holdings Corp | 56.43 | -4381.14% |
| BAX | Baxter International Inc | 63.44 | -4912.66% |
| ICUI | ICU Medical Inc | 74.28 | -5735.47% |
| RGEN | Repligen Corp | 123.98 | -9505.14% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | -17065.27% |
| WRBY | Warby Parker Inc - Class A | 292.87 | -22317.72% |